Newsroom

By Derek Bagley Nov 2023 In August, the insulin management software company Glytec unveiled the latest version of its Glucommander insulin dosing software to make it easier for providers, nurses, and pharmacists to offer optimal, personalized care. More than 300 hospitals in the U.S. use Glytec’s eGlycemic Management System® (eGMS®) for glycemic management for their patients. Glytec chief...

AUGUST 29, 2018 Glytec Receives Two More Patent Allowances for its Insulin Optimization System The newest USPTO allowances describe an integrated, connected care model for optimizing insulin therapy in the outpatient setting. Waltham, MA — The United States Patent and Trademark Office has awarded Glytec two more patent allowances acknowledging the unique characteristics of its disruptive...

MARCH 28, 2018 Two More Patent Allowances for Glytec’s Diabetes Software The latest allowances from the USPTO address systems and methods specific to the dosing of subcutaneous insulin for acute and chronic care. Waltham, MA — The United States Patent and Trademark Office (USPTO) has issued two more patent allowances for Glytec’s FDA-cleared proprietary software used by healthcare providers to...

JUNE 21, 2017

Second allowance covers its unique insulin administration method. Waltham, MA — Glytec, the pioneer and leader in providing innovative glucose management software solutions, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent application directed toward a method of administering insulin proven to improve patient outcomes compared to...